-
Exposed: The black market dealers selling puberty blocker drugs to British teenagers who are cheating ban
11 May 2024 21:48 GMT
… of children.
Medics warned the drugs can damage brain … bought the puberty blocker drugs from three different … shipped a testosterone-blocking drug called bicalutamide from Istanbul. It … Casodex, bicalutamide is a prescription-only medication usually used …
-
FDA Approved Drug Products Approval List March 2024
30 Mar 2024 10:39 GMT
… ORIG-1 RIFAXIMIN NORWICH PHARMACEUTICALS INC Tentative Approval … 761044 SUPPL-13 USTEKINUMAB JANSSEN BIOTECH Approval 03… #078917 SUPPL-13 BICALUTAMIDE ACCORD HLTHCARE Labeling Approval … SUPPL-15 PRALSETINIB BLUEPRINT MEDICINES Labeling Approval 03…
-
Reversibility of Bicalutamide PSMA PET-Positive Gynecomastia With Androgen Deprivation Therapy.
22 Feb 2024 08:18 GMT
… 78-year-old man receiving bicalutamide for prostate cancer was referred … but rarely reported effect of bicalutamide monotherapy. This scan also demonstrated … PSMA-avid bicalutamide-induced gynecomastia is reversible.
Clinical nuclear medicine. 2024 Feb …
-
Prevalence of Medication Associated with QTc Prolongation Used Among Critically Ill Patients
31 Jan 2024 13:41 GMT
… TdP” category includes medications like 5-fluorouracil, alfuzosin, and bicalutamide, which could … citalopram as a less favorable treatment option when compared to other … polypharmacy and risk of potential drug-drug interactions among hospitalized patients with …
-
GnRH antagonist monotherapy versus a GnRH agonist plus bicalutamide for advanced hormone-sensitive prostate cancer; KYUCOG-1401.
29 Dec 2023 03:25 GMT
… a GnRH agonist and bicalutamide in patients with advanced … conducted as KYUCOG-1401 trial (UMIN000014243) and enrolled … agonist and bicalutamide as a more effective treatment for advanced … ., Urology Department, Saga-Ken Medical Centre Koseikan, Saga, Japan., …
-
Pfizer and Astellas' XTANDI® Approved by U.S. FDA in Earlier Prostate Cancer Treatment Setting
17 Nov 2023 12:45 GMT
… Drug Administration (FDA) of a supplemental New Drug Application for XTANDI® (enzalutamide), following FDA … to medical or surgical treatment designed … TERRAIN, the bicalutamide-controlled study of … .
Information about pharmaceutical products (including …
-
Bicalutamide (Casodex) and cost
22 Nov 2023 18:46 GMT
… and your doctor will discuss bicalutamide in regard to your treatment. The insurance … questions about drug cost and bicalutamide.
Does Medicare cover bicalutamide?
It may. Medicare Part D …
-
Treatment Landscape for Metastatic Castrate-Sensitive Prostate Cancer: A Review
13 Nov 2023 04:33 GMT
… trials in mCSPC
ADT Plus Docetaxel for mCSPC
In 2004, the FDA … ADT vs a nonsteroidal antiandrogen drug (bicalutamide, nilutamide, flutamide) plus ADT … CT scans and nuclear medicine bone scans for borderline … a Phase 3 trial to compare treatment with 177Lu-PSMA- …
-
Risk of prostate cancer death after radical radiotherapy with neoadjuvant and adjuvant therapy with bicalutamide or gonadotropin-releasing hormone agonists.
20 Oct 2023 23:56 GMT
Oncological outcome after radical radiotherapy (RRT) combined with neoadjuvant and adjuvant androgen suppression therapy (AST) may differ according to type of AST. The aim of this nationwide register-based study was to investigate risk of prostate cancer ( …
-
Relative search popularity of five advanced prostate cancer medications using Google Trends.
11 Sep 2023 14:33 GMT
There are many FDA-approved drugs for advanced prostate cancer (PC), … determined.
Several drugs abruptly increased in popularity following FDA approval including abiraterone … have bicalutamide as the top search drug vs. states that expanded Medicaid (p …